Annual ROE
-95.37%
+10.48%+9.90%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual return on equity is currently -95.37%, with the most recent change of +10.48% (+9.90%) on 31 December 2023. During the last 3 years, it has risen by +611.79% (+86.51%). BHVN annual ROE is now -101.34% below its all-time high of 7122.91%, reached on 31 December 2019.BHVN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-225.12%
-12.29%-5.77%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly return on equity is currently -225.12%, with the most recent change of -12.29% (-5.77%) on 30 September 2024. Over the past year, it has dropped by -115.06% (-104.54%). BHVN quarterly ROE is now -110.74% below its all-time high of 2095.32%, reached on 01 September 2020.BHVN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.9% | -104.5% |
3 y3 years | +86.5% | +26.5% |
5 y5 years | +40.3% | +57.9% |
BHVN ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +86.5% | -423.0% | +61.6% |
5 y | 5 years | -101.3% | +86.5% | -110.7% | +81.7% |
alltime | all time | -101.3% | +89.2% | -110.7% | +81.7% |
Biohaven Pharmaceutical Holding ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -225.12%(+5.8%) |
June 2024 | - | -212.83%(+44.7%) |
Mar 2024 | - | -147.06%(+42.1%) |
Dec 2023 | -95.37%(-9.9%) | -103.50%(-6.0%) |
Sept 2023 | - | -110.06%(-4.3%) |
June 2023 | - | -114.99%(-27.4%) |
Mar 2023 | - | -158.35%(-16.6%) |
Dec 2022 | -105.85%(-82.8%) | -189.84%(-40.3%) |
Sept 2022 | - | -318.07%(+16.1%) |
June 2022 | - | -273.86%(-53.3%) |
Mar 2022 | - | -585.98%(+91.3%) |
Dec 2021 | -616.29%(-12.8%) | - |
Dec 2021 | - | -306.28%(-539.4%) |
Sept 2021 | - | 69.70%(-49.1%) |
June 2021 | - | 137.01%(-50.9%) |
Mar 2021 | - | 279.15%(-53.0%) |
Dec 2020 | -707.16% | - |
Dec 2020 | - | 594.12%(-71.6%) |
Sept 2020 | - | 2095.32%(-270.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2020 | - | -1230.64%(+102.2%) |
Mar 2020 | - | -608.62%(+13.7%) |
Dec 2019 | 7122.91%(-4561.9%) | - |
Dec 2019 | - | -535.09%(+70.5%) |
Sept 2019 | - | -313.77%(+0.8%) |
June 2019 | - | -311.35%(+54.6%) |
Mar 2019 | - | -201.37%(-7.4%) |
Dec 2018 | -159.64%(+65.6%) | - |
Dec 2018 | - | -217.35%(+8.1%) |
Sept 2018 | - | -200.98%(+32.8%) |
June 2018 | - | -151.30%(+14.9%) |
Mar 2018 | - | -131.72%(+10.7%) |
Dec 2017 | -96.38%(-168.2%) | - |
Dec 2017 | - | -119.02%(-40.8%) |
Sept 2017 | - | -200.88%(-43.2%) |
June 2017 | - | -353.48%(-319.2%) |
Mar 2017 | - | 161.26%(+14.0%) |
Dec 2016 | 141.40%(-116.1%) | - |
Dec 2016 | - | 141.40% |
Dec 2015 | -879.55% | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual return on equity?
- What is the all time high annual ROE for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual ROE year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly return on equity?
- What is the all time high quarterly ROE for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly ROE year-on-year change?
What is Biohaven Pharmaceutical Holding annual return on equity?
The current annual ROE of BHVN is -95.37%
What is the all time high annual ROE for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual return on equity is 7122.91%
What is Biohaven Pharmaceutical Holding annual ROE year-on-year change?
Over the past year, BHVN annual return on equity has changed by +10.48% (+9.90%)
What is Biohaven Pharmaceutical Holding quarterly return on equity?
The current quarterly ROE of BHVN is -225.12%
What is the all time high quarterly ROE for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly return on equity is 2095.32%
What is Biohaven Pharmaceutical Holding quarterly ROE year-on-year change?
Over the past year, BHVN quarterly return on equity has changed by -115.06% (-104.54%)